Hong-fei Gao
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Timing of Pegfilgrastim Administration and Pegfilgrastim-Induced Bone Pain : A Prospective, Randomized, Phase 3 Trial.
Journal: Annals of internal medicine
Published: March 23, 2026
Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 23, 2026
ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report.
Journal: AME case reports
Published: April 23, 2025
Pooled analysis of NeoCARH and NeoCART trials: patient-reported outcomes in patients with early-stage breast cancer receiving platinum-based or anthracycline-based neoadjuvant chemotherapy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: December 09, 2023
Clinical efficacy of tumor organoid-guided cancer therapy for locally advanced unresectable or metastatic breast cancer.
Journal: International journal of cancer
Published: August 27, 2023
Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis.
Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis.
Journal: Breast (Edinburgh, Scotland)
Published: April 07, 2022
Higher efficacy of resveratrol against advanced breast cancer organoids: A comparison with that of clinically relevant drugs.
Journal: Phytotherapy research : PTR
Published: March 09, 2022
Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 10, 2022
Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures.
Journal: Frontiers in molecular biosciences
Published: August 16, 2021
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple-negative, early-stage breast cancer (NeoCART): Results from a multicenter, randomized controlled, open-label phase II trial.
Journal: International journal of cancer
Published: June 09, 2021
Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials.
Journal: Breast (Edinburgh, Scotland)
Published: April 26, 2021
Peritoneal Metastasis After Treated With Abemaciclib Plus Fulvestrant for Metastatic Invasive Lobular Breast Cancer: A Case Report and Review of the Literature.
Journal: Frontiers in endocrinology
Published: February 11, 2021
Last Updated: 09/26/2026